Top

Senseonics wins CE Mark for Eversense XL glucose monitor

September 13, 2017

Senseonics (NYSE:SENS) said yesterday that it won CE Mark approval in the European Union for its Eversense XL continuous glucose monitor.

The Eversense XL includes a glucose sensor designed to be implanted for 180 days and a removable smart transmitter that links with a mobile app for real-time glucose monitoring. Germantown, Md.-based Senseonics touts the sensor as the world’s longest lasting compared with others that require weekly insertions.

Read More on Mass Device